thyssenkrupp nucera AG & Co KgaA
F:NCH2
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.305
11.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
thyssenkrupp nucera AG & Co KgaA
Thyssenkrupp nucera AG & Co KGaA stands as a testament to industrial prowess, building upon a rich heritage of engineering excellence rooted deep within the Thyssenkrupp conglomerate. As a significant player in the field of industrial engineering, nucera focuses primarily on the production of technologically advanced electrolysis plants. These systems are the backbone of their operations, enabling the transformation of water into hydrogen and oxygen using electricity—a process pivotal for numerous industrial applications. By capitalizing on the rising demand for green and sustainable energy solutions, nucera aligns itself with global sustainability trends, offering solutions that cater to chemical, energy, and utility companies worldwide.
The company's financial model hinges on the deployment of large-scale electrolysis plants, maintenance services, and providing technological advancements to bolster efficiency and productivity. Revenue flows from a mix of engineering contracts and long-term service agreements, which ensure a steady inflow of income post-installation. This strategic focus is reinforced by their commitment to research and innovation, continuously refining their offerings to maintain competitive edge and operational excellence. By blending sound engineering with a vision towards sustainable practices, Thyssenkrupp nucera positions itself as a key contributor to an energy-efficient future, satisfying industrial needs while addressing the imperatives of environmental stewardship.
Thyssenkrupp nucera AG & Co KGaA stands as a testament to industrial prowess, building upon a rich heritage of engineering excellence rooted deep within the Thyssenkrupp conglomerate. As a significant player in the field of industrial engineering, nucera focuses primarily on the production of technologically advanced electrolysis plants. These systems are the backbone of their operations, enabling the transformation of water into hydrogen and oxygen using electricity—a process pivotal for numerous industrial applications. By capitalizing on the rising demand for green and sustainable energy solutions, nucera aligns itself with global sustainability trends, offering solutions that cater to chemical, energy, and utility companies worldwide.
The company's financial model hinges on the deployment of large-scale electrolysis plants, maintenance services, and providing technological advancements to bolster efficiency and productivity. Revenue flows from a mix of engineering contracts and long-term service agreements, which ensure a steady inflow of income post-installation. This strategic focus is reinforced by their commitment to research and innovation, continuously refining their offerings to maintain competitive edge and operational excellence. By blending sound engineering with a vision towards sustainable practices, Thyssenkrupp nucera positions itself as a key contributor to an energy-efficient future, satisfying industrial needs while addressing the imperatives of environmental stewardship.
Sales Slightly Below Guidance: Group sales for the fiscal year were slightly below the EUR 845 million guidance, primarily due to weaker green hydrogen sales.
Return to Positive EBIT: thyssenkrupp nucera delivered positive EBIT of EUR 2 million, reflecting an improved project mix and cost discipline.
Chlor-Alkali Segment Shines: Chlor-alkali sales hit a record EUR 387 million, with 60% from services and new contracts, including the largest single project win ever.
Order Intake Drops: Total order intake fell 45% year-on-year to EUR 348 million, mainly due to reduced green hydrogen demand and project delays.
Strong Financial Position: Net financial assets remained robust at EUR 656 million, and free cash flow turned positive at EUR 11 million.
Guidance for 2025–26: Management expects group sales of EUR 500–600 million and EBIT between minus EUR 30 million and EUR 0 million next year, reflecting lower planned sales and continued cost controls.
Green Hydrogen Outlook: Market headwinds persist, but management remains optimistic about long-term potential and is focusing on a high-quality, mature project pipeline.